| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 5703 | 2021 |
| Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel … SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ... Circulation 116 (25), 2923-2932, 2007 | 1830* | 2007 |
| Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ... Jama 305 (11), 1097-1105, 2011 | 1634 | 2011 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1366 | 2010 |
| Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives DJ Angiolillo, A Fernandez-Ortiz, E Bernardo, F Alfonso, C Macaya, ... Journal of the American College of Cardiology 49 (14), 1505-1516, 2007 | 1261 | 2007 |
| Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk P Urban, R Mehran, R Colleran, DJ Angiolillo, RA Byrne, D Capodanno, ... Circulation 140 (3), 240-261, 2019 | 952 | 2019 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 942 | 2013 |
| Effect of platelet inhibition with cangrelor during PCI on ischemic events DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ... New England Journal of Medicine 368 (14), 1303-1313, 2013 | 927 | 2013 |
| Ticagrelor with or without aspirin in high-risk patients after PCI R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, ... New England Journal of Medicine 381 (21), 2032-2042, 2019 | 901 | 2019 |
| Ticagrelor or prasugrel in patients with acute coronary syndromes S Schüpke, FJ Neumann, M Menichelli, K Mayer, I Bernlochner, J Wöhrle, ... New England Journal of Medicine 381 (16), 1524-1534, 2019 | 792 | 2019 |
| Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies R Moreno, C Fernández, R Hernández, F Alfonso, DJ Angiolillo, M Sabaté, ... Journal of the American College of Cardiology 45 (6), 954-959, 2005 | 792 | 2005 |
| A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation … D Trenk, GW Stone, M Gawaz, A Kastrati, DJ Angiolillo, U Müller, ... Journal of the American College of Cardiology 59 (24), 2159-2164, 2012 | 784 | 2012 |
| Platelet inhibition with cangrelor in patients undergoing PCI RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, ... New England Journal of Medicine 361 (24), 2318-2329, 2009 | 752 | 2009 |
| Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment DJ Angiolillo, A Fernandez-Ortiz, E Bernardo, C Ramírez, M Sabaté, ... Diabetes 54 (8), 2430-2435, 2005 | 707 | 2005 |
| Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in … DJ Angiolillo, SB Shoemaker, B Desai, H Yuan, RK Charlton, E Bernardo, ... Circulation 115 (6), 708-716, 2007 | 638 | 2007 |
| Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial DJ Angiolillo, MS Firstenberg, MJ Price, PE Tummala, M Hutyra, IJ Welsby, ... Jama 307 (3), 265-274, 2012 | 570 | 2012 |
| Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ... European heart journal 31 (24), 3006-3016, 2010 | 554 | 2010 |
| Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial KW Mahaffey, DM Wojdyla, K Carroll, RC Becker, RF Storey, DJ Angiolillo, ... Circulation 124 (5), 544-554, 2011 | 530 | 2011 |
| Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay … MJ Price, DJ Angiolillo, PS Teirstein, E Lillie, SV Manoukian, PB Berger, ... Circulation 124 (10), 1132-1137, 2011 | 521 | 2011 |
| Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease JL Mega, W Hochholzer, AL Frelinger, MJ Kluk, DJ Angiolillo, ... Jama 306 (20), 2221-2228, 2011 | 514 | 2011 |
